Sign in

CIK 0001720580

  • Non-accelerated filer
  • Smaller reporting company

Adicet Bio, Inc.

Sign in to watch
Ticker
ACET
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 26
Incorporated
DE
Entity type
Operating
EIN
813305277
Phone
+1 617-482-2333
Business address
131 DARTMOUTH STREET, 3RD FLOOR, BOSTON, MA, 02116
Former names
resTORbio, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 50 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-02-14 Aftab Blake Chief Scientific Officer Shares withheld for taxes −5,533 $14.27 $79K 52,903
2022-02-14 Galimi Francesco SVP & Chief Medical Officer Grant or award +16,000 65,450
2022-02-14 Galimi Francesco SVP & Chief Medical Officer Shares withheld for taxes −5,533 $14.27 $79K 59,917
2022-02-14 Harvey Brian Nicholas Chief Financial Officer Grant or award +16,000 59,304
2022-02-14 Harvey Brian Nicholas Chief Financial Officer Shares withheld for taxes −4,696 $14.27 $67K 54,608
2022-02-14 Schor Chen President & CEO Grant or award +48,000 170,712
2022-02-14 Schor Chen President & CEO Shares withheld for taxes −21,288 $14.27 $304K 149,424
2022-02-09 Jakobovits Aya Director Sale −4,000 $14.03 $56K 360,343
2022-02-09 Jakobovits Aya Director Sale −4,000 $14.03 $56K 360,345
2022-01-28 Galimi Francesco SVP & Chief Medical Officer Grant or award +16,000 54,983
2022-01-28 Galimi Francesco SVP & Chief Medical Officer Shares withheld for taxes −5,533 $11.69 $65K 49,450
2022-01-28 Healey Don Chief Technology Officer Grant or award +16,000 48,000
2022-01-28 Healey Don Chief Technology Officer Shares withheld for taxes −5,533 $11.69 $65K 42,467
2022-01-28 Aftab Blake Chief Scientific Officer Grant or award +16,000 48,000
2022-01-28 Aftab Blake Chief Scientific Officer Shares withheld for taxes −5,564 $11.69 $65K 42,436
2022-01-28 Harvey Brian Nicholas Chief Financial Officer Grant or award +16,000 48,000
2022-01-28 Harvey Brian Nicholas Chief Financial Officer Shares withheld for taxes −4,696 $11.69 $55K 43,304
2022-01-28 Schor Chen President & CEO Grant or award +48,000 144,000
2022-01-28 Schor Chen President & CEO Shares withheld for taxes −21,288 $11.69 $249K 122,712
2022-01-07 Harvey Brian Nicholas Chief Financial Officer Grant or award · Stock Option (Right to Buy +125,000 125,000

Page 19 of 24 · 478 trades